Proton and Carbon-Ion Therapy in China: What International Patients Should Prepare

Quick Summary

Proton and carbon-ion therapy are forms of external-beam particle radiotherapy. Their dose patterns can reduce radiation exposure beyond a tumor compared with some photon plans, while carbon ions also have different biological properties. Neither option is automatically more suitable because it is newer or more powerful. A radiation oncology team must review the cancer type, pathology, stage, tumor location, nearby organs, previous treatment, current health and a new planning scan. International patients considering care in China should send complete pathology, recent imaging in DICOM format, previous radiotherapy plans and dose records, treatment summaries, laboratory results and a medication list. They should also plan for on-site assessment, simulation, treatment planning, daily sessions, possible side effects and follow-up.

What Are Proton and Carbon-Ion Therapy?

Most external-beam radiotherapy uses photons. Proton therapy uses positively charged particles that release a large part of the dose near the end of their path, a pattern associated with the Bragg peak. This can reduce the exit dose behind the target.

Carbon ions are heavier charged particles with a Bragg-peak pattern, denser ionization and higher relative biological effectiveness. This may matter for selected tumors that are difficult to control with conventional radiation. However, dose calculation, biological modeling and clinical evidence are complex. “Stronger” does not mean “appropriate for every cancer.”

The clinically important question is not whether one machine is more advanced. It is whether a well-designed particle plan offers a meaningful advantage for a specific patient compared with modern photon radiotherapy, surgery, systemic treatment or another approach.

Why International Patients Consider China

Shanghai's official government directory identifies the Shanghai Proton and Heavy Ion Center and lists proton and heavy-ion radiotherapy among its featured services. Reviewed October 1, 2026. Other institutions and services may differ, and not every facility offers both particle types. Accepted indications, language support, payment arrangements and treatment capacity must be confirmed directly with the receiving institution.

MedToChina can receive a patient's records and practical requirements through the website or WhatsApp. The service team can clarify missing information and discuss available coordination steps after the diagnosis, records, country, budget, timing and language needs are understood. Suitability, hospital acceptance and treatment plans must be confirmed by the receiving institution and licensed clinicians.

Who May Be Considered for Particle Therapy?

Proton therapy may be considered when reducing dose to nearby healthy tissue could be clinically important, including selected tumors near sensitive organs, some skull-base or central nervous system tumors, certain pediatric cancers and carefully evaluated re-irradiation. The advantage must be demonstrated through planning, not assumed from the diagnosis.

Carbon-ion therapy has been studied for selected solid tumors, including some chordomas, chondrosarcomas and sarcomas. Evidence differs by tumor type, and many studies are observational or involve limited patient numbers. Reviews report promising results in several settings but call for stronger comparisons.

An assessment may be less straightforward when:

• Disease is widespread and systemic treatment is the main priority.
• The tumor cannot be clearly defined on current imaging.
• Previous radiation has already delivered substantial dose to the same organs.
• Urgent complications require faster local treatment than travel and planning allow.
• Tumor motion, metal implants or anatomy make a proposed beam path difficult.
• The patient cannot lie still or maintain the required position.
• Infection, severe malnutrition, organ dysfunction or poor general condition needs stabilization.
• Particle therapy would interrupt chemotherapy, immunotherapy or surgery at an unsafe time.

These factors are not automatic exclusions. They are reasons for a radiation oncologist to review the complete situation before travel.

Proton Versus Carbon Ion: Questions to Ask

Patients sometimes ask which particle is “better.” A safer question is which plan, if any, improves the balance between tumor dose and normal-tissue exposure for this case.

Ask the reviewing team:

• What is the treatment goal: cure, local control, consolidation or symptom relief?
• Why is proton or carbon-ion therapy being considered for this tumor?
• What modern photon alternatives are relevant?
• Can a comparative dose plan show differences for nearby organs?
• What clinical evidence supports the proposed approach for this cancer and stage?
• How does previous surgery, systemic therapy or radiotherapy affect the plan?
• What are the expected short- and long-term risks for the treatment area?
• How many fractions are proposed, and why?

A dose-volume comparison can be useful, but a visually lower dose on a chart is not automatically a proven improvement in survival or quality of life. The physician should explain the expected clinical significance and uncertainty.

Records to Prepare Before a Review in China

1. Pathology and diagnostic confirmation

Send the complete pathology report, not only a short diagnosis. Include biopsy or surgical pathology, immunohistochemistry, molecular findings and any expert pathology review. Ask whether glass slides, paraffin blocks or digital pathology images may be required. Translations should preserve exact histology, grade, margins and biomarker terminology.

2. Recent imaging in DICOM format

Provide the original CT, MRI and PET images when available, together with their written reports. Screenshots or photographs of films are usually not enough for detailed radiation review. DICOM files preserve the full image series, technical information and spatial relationships used in planning.

State the imaging date and whether treatment occurred afterward. New imaging may be necessary if the disease or anatomy could have changed.

3. Previous radiotherapy records

Anyone previously irradiated near the proposed target should request:

• Treatment site and dates
• Technique and machine type
• Total dose and number of fractions
• Dose per fraction
• Planning CT
• DICOM-RT plan, dose and structure files when available
• Dose-volume histograms
• Treatment summary and any interruption record

A statement such as “radiotherapy completed” is insufficient for evaluating cumulative organ dose. If digital files are unavailable, send all paper summaries and identify what is missing.

4. Complete treatment history

Include operative reports, discharge summaries, chemotherapy, targeted therapy, immunotherapy, hormone therapy and prior radiation. Record drug names, doses, cycle dates, response, progression and significant toxicity. Mention implanted devices, prostheses, metal hardware, pacemakers and vascular ports.

5. Current clinical information

Provide recent blood counts, liver and kidney function, performance status if documented, current symptoms, weight trend, infections, wounds and nutritional concerns. List every prescription drug, over-the-counter medicine and supplement, including anticoagulants and steroids. Report allergies and the reaction caused.

What Happens After Records Are Submitted?

Step 1: Preliminary record review

The available documents may show whether a formal particle-therapy assessment is reasonable and what information is missing. This stage does not confirm suitability or reserve treatment capacity.

Step 2: On-site evaluation

The institution may repeat examinations, laboratory tests, pathology review or staging scans. If the disease has changed, the strategy may change. Avoid inflexible travel arrangements until the steps and timeline are understood.

Step 3: Simulation and immobilization

Planning usually requires a simulation CT in the treatment position. A customized mask, cradle or body mold may reproduce the position each day. Some sites require contrast, breathing assessment, bladder or bowel preparation, or markers. Follow case-specific instructions.

Step 4: Planning and quality assurance

Radiation oncologists define the target and organs at risk. Physicists calculate beam angles, energy and dose and perform technical checks. Particle plans are sensitive to anatomy, density and motion.

Step 5: Treatment sessions

Treatment is commonly outpatient, but fraction number and frequency vary. Positioning and imaging often take longer than beam delivery, and the same preparation may be required daily.

Step 6: Monitoring and follow-up

The team monitors symptoms and organ-specific effects. Follow-up depends on the cancer and treatment goal. Obtain a treatment summary for the doctor continuing care at home.

Side Effects and Safety Questions

Particle therapy can reduce dose to selected normal tissues, but it does not eliminate side effects. Effects depend on the treated area, dose, fractionation, previous treatment and health. Fatigue may develop. Head and neck treatment may affect skin, mouth or swallowing; chest treatment may irritate the esophagus or lung; abdominal or pelvic treatment may affect appetite, bowel or urinary function. Late effects can appear later.

External-beam particle therapy does not make the patient radioactive. Patients should still ask about site-specific precautions, emergency symptoms and whether treatment could affect travel fitness.

Previous radiation deserves particular attention because normal tissues have cumulative dose limits. Re-irradiation may be possible in selected cases, but it requires the earlier dose distribution and a careful risk discussion.

Plan the Stay in China Around the Full Course

Planning should cover the entire care course, not only beam-delivery days. The practical burden may include simulation before treatment, repeated travel to the center, daily bladder or bowel preparation, accommodation for several weeks, and side effects that can accumulate during or after treatment.

Before travel, confirm:

• Expected time from arrival to assessment and simulation
• Planning time before the first fraction
• Proposed number of sessions and treatment days
• Whether weekends or public holidays affect the schedule
• Accommodation distance from the treatment center
• Need for a caregiver after sedation or during worsening symptoms
• Language support for consent and daily instructions
• Estimated charges and what is excluded
• Payment timing, deposit and refund process
• Plan for unexpected tests, delays or treatment changes
• When the treating team may consider the patient fit to travel home

Do not build flights around an estimated final fraction before the clinical schedule is confirmed. Leave flexibility for reassessment, technical interruptions or symptom management.

A Practical Submission Checklist

• Passport name, nationality and contact details
• Preferred spoken and written language
• Diagnosis, pathology and molecular reports
• Recent CT, MRI and PET images in DICOM format
• Imaging reports and dates
• Previous radiotherapy plan, dose and structure files
• Surgery and systemic-treatment summaries
• Current laboratory results, medicines and allergies
• Current symptoms, mobility and nutritional status
• Implanted devices or metal hardware
• Intended travel period and companion information
• Main questions about treatment goal, risks, schedule and follow-up

Organize files by date and label them in English. Keep original-language documents alongside translations. Do not alter medical units, staging terms, negative findings, drug names or radiation doses during translation.

Frequently Asked Questions

Is proton therapy always safer than photon radiotherapy?

No. Proton plans can reduce dose beyond the target in some cases, but clinical value depends on anatomy, tumor motion, plan quality and the organ at risk. Modern photon therapy may be equally appropriate for many patients. Ask for a case-specific explanation.

Is carbon-ion therapy stronger than proton therapy?

Carbon ions have higher linear energy transfer and biological effectiveness, but that does not make them universally preferable. The evidence, dose model, tumor biology and risk to nearby tissue must be considered for each indication.

Can a medical report alone confirm suitability?

Usually not. A preliminary review may identify whether further assessment is reasonable. Final decisions commonly require original imaging, pathology confirmation, examination and a new simulation scan.

Why are previous radiation files so important?

They show where dose was delivered and how much nearby organs received. Without them, the team may be unable to estimate cumulative dose and re-irradiation risk accurately.

How long should I stay in China?

The answer depends on assessment, simulation, planning, fractionation and recovery. Some courses involve only a few fractions; others extend over several weeks. Request a provisional schedule with contingency time before booking travel.

Will I need to stay in the hospital?

Many particle-therapy courses are outpatient. Admission may be needed because of the cancer, concurrent treatment, complications or general condition rather than the beam type itself.

Can particle therapy treat metastatic cancer?

It is a local treatment. It may have a role for selected sites or symptoms, but widespread disease often requires systemic management. The oncology team must define the overall treatment strategy.

What should I ask about cost?

Ask for the components of the estimate: assessment, imaging, pathology review, simulation, planning, quality assurance, treatment fractions, medicines, admission and follow-up. Also ask what could change the estimate.

Related MedToChina Resources

• Cancer mutation reports and targeted-therapy questions
• China cancer-trial eligibility checklist
• China-ready medical records checklist
• Medical clearance before treatment in China
• Language support in Chinese hospitals

Submit Your Records or Contact Us on WhatsApp

If you are considering proton or carbon-ion therapy in China, submit your diagnosis summary, pathology, recent DICOM imaging, previous treatment records and intended travel period through MedToChina, or contact the service team on WhatsApp. Include any previous radiotherapy and your preferred language. The team can review whether the information is complete and discuss the next practical communication steps with you.

Medical Disclaimer

This article provides general educational and travel-preparation information. It is not medical advice, a clinical diagnosis, confirmation of suitability or a treatment recommendation. Particle-therapy indications, protocols, risks, availability, fees and timelines vary by institution and patient. Final decisions must be made by licensed clinicians after a complete assessment. Seek urgent local medical care for an emergency or rapidly worsening symptoms.

References

1. National Cancer Institute. External Beam Radiation Therapy for Cancer.
2. National Cancer Institute. Radiation Therapy to Treat Cancer.
3. American Society for Radiation Oncology. Proton Beam Therapy Model Policy.
4. International Atomic Energy Agency. DIRAC: Radiotherapy Equipment and Particle Accelerators.
5. Shanghai Municipal Government. Shanghai Proton and Heavy Ion Center.
6. Yun JE, et al. Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis. Yonsei Medical Journal. 2024.
7. Jang JY, et al. A Meta-Analysis Comparing Efficacy and Safety Between Proton Beam Therapy and Carbon Ion Radiotherapy. Cancer Medicine. 2024.
8. Choi SH, et al. Clinical Indications and Future Directions of Carbon-Ion Radiotherapy: A Narrative Review. Ewha Medical Journal. 2024.